AP NEWS
Click to copy
Press release content from Business Wire. The AP news staff was not involved in its creation.
Click to copy
PRESS RELEASE: Paid content from Business Wire
Press release content from Business Wire. The AP news staff was not involved in its creation.

Bristol-Myers Squibb to Take Part in the UBS Global Healthcare Conference

May 14, 2019

NEW YORK--(BUSINESS WIRE)--May 14, 2019--

Bristol-Myers Squibb Company (NYSE: BMY) will take part in a fireside chat at the UBS Global Healthcare Conference on Tuesday, May 21, 2019, in New York. Giovanni Caforio, M.D., chairman and chief executive officer will answer questions at 2:30 p.m. ET.

Investors and the general public are invited to listen to a live webcast of the session at http://investor.bms.com. Materials related to the presentation will be available at the same website at the start of the live webcast. An archived edition of the session will be available later that day.

About Bristol-Myers Squibb

Bristol-Myers Squibb is a global biopharmaceutical company whose mission is to discover, develop and deliver innovative medicines that help patients prevail over serious diseases. For more information about Bristol-Myers Squibb, visit us at  BMS.com  or follow us on LinkedInTwitter, YouTube and Facebook.

View source version on businesswire.com:https://www.businesswire.com/news/home/20190514005094/en/

CONTACT: Media: Carrie Fernandez, 609-252-5222,carrie.fernandez@bms.com

Investors: Tim Power, 609-252-7509,timothy.power@bms.com

KEYWORD: UNITED STATES NORTH AMERICA NEW YORK

INDUSTRY KEYWORD: HEALTH BIOTECHNOLOGY PHARMACEUTICAL OTHER HEALTH GENERAL HEALTH

SOURCE: Bristol-Myers Squibb Company

Copyright Business Wire 2019.

PUB: 05/14/2019 06:59 AM/DISC: 05/14/2019 06:59 AM

http://www.businesswire.com/news/home/20190514005094/en

All contents © copyright 2019 The Associated Press. All rights reserved.